Type 1 Gaucher disease

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:affects liver
bone marrow
spleen
gptkbp:associated_with increased risk of certain cancers
gptkbp:can_lead_to osteoporosis
pulmonary complications
hepatomegaly
splenomegaly
gptkbp:caused_by neurological symptoms
growth retardation
glucocerebrosidase deficiency
gastrointestinal symptoms
delayed puberty
gptkbp:descendant autosomal recessive
gptkbp:first_described_by gptkb:Philippe_Gaucher
gptkbp:focuses_on patient advocacy groups
https://www.w3.org/2000/01/rdf-schema#label Type 1 Gaucher disease
gptkbp:includes genetic counseling programs
gptkbp:is_affected_by gptkb:healthcare_organization
gptkb:hospital
stress
pregnancy
gptkbp:is_associated_with quality of life issues
reduced life expectancy
gptkbp:is_characterized_by accumulation of glucocerebrosides
gptkbp:is_compared_to Type 2 Gaucher disease
Type 3 Gaucher disease
gptkbp:is_linked_to mutations in GBA gene
gptkbp:is_monitored_by gptkb:hospital
gptkbp:is_often_depicted_as females
gptkbp:is_often_used_in certain ethnic groups
gptkbp:is_part_of lysosomal storage disorders
gptkbp:is_popular_in gptkb:Ashkenazi_Jewish_population
gptkbp:is_recognized_by medical community
gptkbp:is_studied_in clinical trials
gptkbp:issues healthcare providers
gptkbp:managed_by physical therapy
regular monitoring
supportive care
pain management
gptkbp:reports_to gptkb:academic_journal
gptkbp:research ongoing for new treatments
ongoing for gene therapy
ongoing for biomarkers
ongoing for disease mechanisms
gptkbp:scientific_classification non-neuronopathic form
gptkbp:social_responsibility genetic testing
blood test
childhood or adulthood
gptkbp:subject public health initiatives
gptkbp:symptoms gptkb:fandom
fatigue
bruising
bone pain
gptkbp:treatment gptkb:physicist
substrate reduction therapy
oral medications
intravenous infusions
gptkbp:bfsParent gptkb:Cerezyme
gptkbp:bfsLayer 5